Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 10.98M
December 31, 2025 8.817M
September 30, 2025 10.55M
June 30, 2025 7.159M
March 31, 2025 9.89M
December 31, 2024 4.737M
September 30, 2024 7.819M
June 30, 2024 6.848M
March 31, 2024 7.796M
December 31, 2023 7.092M
September 30, 2023 2.914M
June 30, 2023 4.07M
March 31, 2023 3.237M
December 31, 2022 1.516M
September 30, 2022 3.611M
June 30, 2022 1.604M
March 31, 2022 5.89M
December 31, 2021 6.493M
September 30, 2021 6.683M
June 30, 2021 5.016M
March 31, 2021 5.016M
December 31, 2020 8.407M
September 30, 2020 7.602M
June 30, 2020 8.981M
March 31, 2020 7.149M
Date Value
December 31, 2019 9.715M
September 30, 2019 9.629M
June 30, 2019 10.39M
March 31, 2019 12.48M
December 31, 2018 10.71M
September 30, 2018 11.71M
June 30, 2018 7.408M
March 31, 2018 6.537M
December 31, 2017 6.132M
September 30, 2017 6.74M
June 30, 2017 4.923M
March 31, 2017 4.036M
December 31, 2016 2.471M
September 30, 2016 2.168M
June 30, 2016 2.294M
March 31, 2016 1.452M
December 31, 2015 1.053M
September 30, 2015 0.493M
June 30, 2015 0.697M
March 31, 2015 1.475M
December 31, 2014 1.973M
September 30, 2014 3.609M
June 30, 2014 3.188M
March 31, 2014 1.926M
December 31, 2013 1.554M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 5.603B
AngioDynamics, Inc. 53.86M
Alphatec Holdings, Inc. 118.66M
AtriCure, Inc. 167.79M
Baxter International, Inc. 2.15B